Delivery Order SPE2DR25D1053-SPE2DR26FV742
- Not listed
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- The Defense Logistics Agency awarded a delivery order valued at $35,243.16 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 16, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 20, 2026, and performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under Amerisourcebergen's existing Indefinite...
- The Defense Logistics Agency awarded a $41,246.60 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $6,497.25 delivery order by the Defense Logistics Agency on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under Amerisourcebergen's...
- The Defense Logistics Agency awarded a $30,629.33 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $9,747.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The order, with an ultimate completion date of January 23, 2026, was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at approximately $46,000 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with performance completion targeted for January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a $15,982.03 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors under a firm fixed-price contract. The award, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, represents a non-set-aside competitive procurement. This delivery order is a child contract executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $25,850.44 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 25, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle that runs through December 2026. The...
- The Defense Logistics Agency awarded a $7,975.00 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors under a firm fixed-price contract on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-competitive delivery order is issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV742Delivery Order
The Defense Logistics Agency awarded a $30,283.68 delivery order to AmerSourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 22, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 23, 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. Repatha (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in eligible patients. As a critical pharmaceutical distributor to federal military and veteran healthcare systems, AmerSourceBergen Drug Corp regularly supplies specialty medications, brand-name drugs, vaccines, and medical devices through its DLA contract vehicle. This delivery order fulfills ongoing pharmaceutical supply needs for the Defense Health Agency and related military treatment facilities, demonstrating the contractor's role as a key vendor in the federal medical supply chain serving global military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.3k | 1/21/26 |